Skip to main content
. 2002 Jul 22;2002(3):CD003043. doi: 10.1002/14651858.CD003043

Barrioz 1994.

Methods Generation of the allocation sequence: method unclear. 
 Allocation concealment: method unclear. 
 Blinding: Not blinded. 
 Intention‐to‐treat: not stated. 
 Exclusions from analysis: not stated. 
 Follow up period: 
 unclear. 
 Jadad‐score: 2.
Participants Twenty patients with malignant biliary stricture and endoscopically inserted biliary polyethylene stent.
Interventions Ursodeoxycholic acid (13‐15 mg/kg/d) and norfloxacin (400 mg/d) versus no treatment.
Outcomes Duration of stent patency. 
 Mortality. 
 Duration of hospitalisation.
Notes Cholangiocarcinoma was more common in the drug treated group.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear